Show Summary Details
Page of

Chronic kidney disease stages 1–3 

Chronic kidney disease stages 1–3
Chronic kidney disease stages 1–3

Althea Mahon

, Karen Jenkins

, and Lisa Burnapp

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 27 February 2021

Identification and prevalence of CKD

Stages of CKD

Stages 1–3 CKD screening and monitoring

Referral criteria

Proteinuria management

Management of co-morbidities

Interface with primary care

Further reading

CKD affects ~10% of the adult population worldwide. Stage 3–5 CKD is present in 6–7% of the adult UK population. More people are now aware of having reduced kidney function or proteinuria as a result of the consensus and subsequent publication of various CKD guidelines, such as NICE, KDOQI, and the UK Renal Association. These guidelines provide recommendations for clinical practice and include regular measurement and reporting of kidney function. Registers such as the quality outcomes framework (QOF) used in general practice, records the prevalence of CKD. The CKD register ensures an annual assessment of kidney function for people in high-risk groups....

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.